VF
IRLA

Virtu Financial’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Virtu Financial’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-79
Closed -$53K – 2174
2025
Q4 		$53K Buy
+79
New +$39.8K ﹤0.01% 1296
2025
Q2 		– Sell
-217
Closed -$58K – 1941
2025
Q1 		$58K Buy
217
+71
+49% +$21.7K ﹤0.01% 994
2024
Q4 		$55K Buy
+146
New +$43.9K ﹤0.01% 1145
2021
Q3 		– Sell
-27
Closed -$286K – 1874
2021
Q2 		$286K Buy
+27
New +$226K 0.03% 751
2020
Q3 		– Sell
-36
Closed -$336K – 1422
2020
Q2 		$336K Buy
+36
New +$330K 0.04% 509

Other funds holding IRLA

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Virtu Financial's IRLA Position: Q1 2026 in Review

Virtu Financial sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q1 2026, closing a stake of 79 shares — an estimated $53K sold.

Virtu Financial first reported a position in IRLA in Q2 2020 and held it in 5 quarters. The position peaked at $336K in Q2 2020. 43 funds tracked by Wall St. Rank hold IRLA as of Q1 2026.

  • Virtu Financial reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 79 IRulya Therapeutics Inc. Common Stock shares in Q1 2026, an estimated $53K.
  • Virtu Financial first reported a position in IRulya Therapeutics Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Virtu Financial's IRulya Therapeutics Inc. Common Stock position peaked at $336K in Q2 2020.
  • 43 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.